NEW HIGH-ORDER ELEMENTS FOR EFFICIENT MULTIDISCIPLINARY ANALYSIS
Martin Engineering · National Aeronautics and Space Administration
Phase I1996$69,931
N/A
Public Market Intelligence
SBIR/STTR Research Awards
Explore federally funded small business innovation research, technology awards, participating companies, and agency investments.
Company count, total reported award value are not available for this view.
- View Award
- View Award
NOVEL CHEMILUMINESCENT DETECTION OF GENE REARRANGEMENTS
LUMIGEN, INC. · Department of Health and Human Services
Phase I1997$100,000
The objective of Phase I is to develop simple, sensitive and unambiguous chemiluminescent detection of juxtaposed genes in chromosomal translocations associated with many cancers. We propose chemiluminescent assay forma…
View Award - View Award
Novel Method for DBP Precursor Removal
Universal Fuel Development · Environmental Protection Agency
Phase II1995$220,000
The treatment and disinfection of water for drinking continues to be a major public health issue. It is clear that disinfection methods involving chlorine compounds result in the formation of byproducts that constitute…
View Award View Award View Award - View Award
Novel System to Automate Zebrafish Angiogenesis Assays
PHYSICAL SCIENCES INC. · Department of Health and Human Services
Phase I2005$129,723
DESCRIPTION (provided by applicant): The zebrafish, Danio rerio, has become widely accepted as a model for human disease. There is strong interest in developing zebrafish as a model organism for use in high throughput d…
- View Award
Next Generation Narrow Band Absorbers for Laser Eye Protection
EXCITON, INC. · Department of Defense
Phase II2000$749,979
N/A
- View Award
Novel Targeted Cytokine for Chronic Kidney Disease
Panorama Research Incorporated · Department of Health and Human Services
Phase I2014$224,243
DESCRIPTION (provided by applicant): Novel Targeted Cytokine for Chronic Kidney Disease End stage renal disease (ESRD) affects gt485,000 Americans, including over 341,000 hemodialysis patients with an estimated 90,000 n…
- View Award
Not Available
STOTTLER HENKE ASSOCIATES, INC · National Aeronautics and Space Administration
Phase I2000$70,000
N/A
- View Award
Not Available
CONTINUUM DYNAMICS INC · Environmental Protection Agency
Phase I2000$69,521
Not Available State-of-the-art thermal control technologies are limited in their ability and increasingly unsatisfactory in their ability to provide the performance desired for chip level electronics and aerospace appli…
- View Award
NO-donor/SOD-mimetics for diabetic nephropathy
MANDALMED, INC. · Department of Health and Human Services
Phase I2005$134,000
DESCRIPTION (provided by applicant): Vascular disease is the principal cause of morbidity and mortality in patients with diabetes, leading to nephropathy, retinopathy, neuropathy, and ischemic disease. Hyperglycemic dam…
- View Award
Nornicotine for Treatment of Pain
YAUPON THERAPEUTICS, INC. · Department of Health and Human Services
Phase I2007$172,935
DESCRIPTION (provided by applicant): The treatment of pain is a critical health issue affecting tens of millions of people annually in the US. Chronic pain (cancer and nonmalignant pain) management is an especially chal…
View Award - View Award
Near-Absolute Net-Shape Processing of Reinforced Aluminum Castings for Brake Calipers
METAL MATRIX CAST COMPOSITES, LLC (DBA M · Department of Defense
Phase I1994$99,157
N/A
- View Award
New Diagnostics for Amebiasis
TECHLAB, INC. · Department of Health and Human Services
Phase I2004$979,495
DESCRIPTION (provided by applicant): Entamoeba histolytica, the cause of amoebiasis, is a Category B pathogen considered in the top three biodefense parasites because it is difficult to diagnose. The disease caused by t…
- View Award
Not Available
Thermal Technologies, Inc. · Department of Health and Human Services
Phase II1999$711,739
N/A
- View Award
NOVEL, NEMATODE-SPECIFIC ANTHELMINTICS AND NEMATICIDES
CAMBRIDGE NEUROSCIENCE · Department of Health and Human Services
Phase I1988$50,000
N/A
- View Award
Not Available
STC BIOLOGICS, INC · Department of Health and Human Services
Phase I2010$299,881
The goal of this project is to develop STC trastuzumab, a generic version of Herceptin. Trastuzumab is a monoclonal antibody made against the HER2 protein that is overexpressed in 20-25% of patients with breast cancer.…
View Award View Award - View Award
NONINVASIVE MAGNETIC SENSOR FOR MAGNETOENCEPHALOGRAPHY (MEG)
Optech · Department of Health and Human Services
Phase II1986$420,045
A SURVEY WITHIN THE MEDICAL COMMUNITY REVEALED THAT A LOW-COST NONSUPERCONDUCTING INSTRUMENT CAPABLE OF MONITORING MAGNETIC FIELDS IS REQUIRED FOR NONINVASIVE MAGNETOENCEPHALOGRAPHY (MEG). SUCH A DEVICE IS ALSO EXPECTED…
View Award - View Award
Not Available
NanoSciences Corporation/NanoSystems Inc · National Science Foundation
Phase I2000$100,000
N/A